Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct;183(4):782-784.
doi: 10.1111/bjd.19348. Epub 2020 Jul 28.

Chilblain-like lesions during the COVID-19 pandemic: a serological study on a case series

L Rizzoli  1 , L Collini  2 , M Magnano  1 , S Termine  1 , R Barcelli  3 , S D Infusino  1 , P Bauer  1 , G Rech  1 , C R Girardelli  1 , R Balestri  1
Affiliations

Chilblain-like lesions during the COVID-19 pandemic: a serological study on a case series

L Rizzoli et al. Br J Dermatol. 2020 Oct.
No abstract available

PubMed Disclaimer

References

    1. Balestri R, Termine S, Rech G, Girardelli CR. Late onset of acral necrosis after SARS‐CoV‐2 infection resolution. J Eur Acad Dermatol Venereol 2020; 10.1111/jdv.16668 - DOI - PMC - PubMed
    1. Fernandez‐Nieto D, Jimenez‐Cauhe J, Suarez‐Valle A et al. Characterization of acute acro‐ischemic lesions in non‐hospitalized patients: a case series of 132 patients during the COVID‐19 outbreak. J Am Acad Dermatol 2020; 83:e61–3. - PMC - PubMed
    1. Galván Casas C, Català A, Carretero Hernández G et al. Classification of the cutaneous manifestations of COVID‐19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol 2020; 183:71–7. - PMC - PubMed
    1. Docampo‐Simón A, Sánchez‐Pujol MJ, Juan‐Carpena G et al. Are chilblain‐like acral skin lesions really indicative of COVID‐19? A prospective study and literature review. J Eur Acad Dermatol Venereol 2020; 10.1111/jdv.16665 - DOI - PMC - PubMed
    1. Guarneri C, Venanzi Rullo E, Gallizzi R et al. Diversity of clinical appearance of cutaneous manifestations in the course of COVID‐19. J Eur Acad Dermatol Venereol 2020; 10.1111/jdv.16669 - DOI - PMC - PubMed

MeSH terms